DJ Regeneron Pharmaceuticals Inc. Stock Underperforms Friday When Compared To Competitors
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Regeneron Pharmaceuticals Inc. $(REGN)$ slipped 1.20% to $733.04 Friday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500 Index falling 0.06% to 6,940.01 and Dow Jones Industrial Average falling 0.17% to 49,359.33.
This was the stock's seventh consecutive day of losses.
Regeneron Pharmaceuticals Inc. closed 10.73% below its 52-week high of $821.11, which the company achieved on January 9th.
The stock underperformed when compared to some of its competitors Friday, as Amgen Inc. $(AMGN)$ rose 0.12% to $330.41, Moderna Inc. (MRNA) rose 6.28% to $41.83, and Gilead Sciences Inc. (GILD) rose 3.01% to $124.91.
Trading volume (1.7 M) eclipsed its 50-day average volume of 978,207.
Data source: Dow Jones Market Data, FactSet. Data compiled January 16, 2026.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
January 16, 2026 16:41 ET (21:41 GMT)
Copyright (c) 2026 Dow Jones & Company, Inc.
Comments